# KEBILIDI

NDC: 52856-601
Generic name: eladocagene exuparvovec-tneq
Labeler / Manufacturer: PTC Therapeutics, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: SUSPENSION
Routes: INTRACEREBRAL
Marketing started: 20241113

FDA application: BLA125722

## Active ingredients

- ELADOCAGENE EXUPARVOVEC: 560000000000 {GC}/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"52856-601"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=52856-601
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9d6a6401-c6b5-4f29-af11-67707d249482